Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Natural history of adult T-cell leukemia/lymphoma and approaches to therapy

Oncogene volume 24, pages 6047–6057 (2005)Cite this article

Abstract

After cell-to-cell transmission, HTLV-I increases its viral genome by de novo infection and proliferation of infected cells. Proliferation of infected cells is clonal and persistent in vivo. During the carrier state, infected cells are selected in vivo by the host's immune system, the genetic and epigenetic environment of proviral integration sites, and other factors. In leukemic cells, tax gene expression is frequently impaired by genetic and epigenetic mechanisms. Such loss of Tax expression enables ATL cells to escape the host immune system. On the other hand, ATL cells acquire the ability to proliferate without Tax by intracellular genetic and epigenetic changes. Despite advances in support and the development of novel treatment agents, the prognosis for ATLL remains poor. A number of therapies, however, do appear to improve prognosis compared to CHOP (VEPA). These include interferon-α plus zidovudine (probably after 1–2 cycles of CHOP), intensive chemotherapy as in LSG-15 with G-CSF support and Allo-SCT (which includes the potential for cure). Emerging novel approaches include HDAC inhibitors, monoclonal antibodies, and proteasome inhibitors. Comparison between different therapeutic approaches is complicated by the range of natural history of ATLL, different recruitments of naïve-to-therapy, refractory or relapsed patients, and variations in the reporting of outcome that frequently excludes difficult-to-evaluate patients. Moreover, results from relatively small proof-of-principle studies have not been extended with randomized, controlled trials. As a result, currently, there is no clear evidence to support the value of any particular treatment approach over others. To avoid further unnecessary patient suffering and to identify optimal therapy as rapidly as possible, large randomized, controlled trials encompassing multicenter, international collaborations will be necessary.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  • Ando Y, Ekuni Y, Matsumoto Y, Nakano S, Saito K, Kakimoto K, Tanigawa T, Kawa M and Toyama T . (2004). J. Obstet. Gynaecol. Res., 30, 436–438.

  • Arai F, Miyamoto T, Ohneda O, Inada T, Sudo T, Brasel K, Miyata T, Anderson DM and Suda T . (1999). J. Exp. Med., 190, 1741–1754.

  • Arima N, Mizoguchi H, Shirakawa S, Tomonaga M, Takatsuki K and Ohno R . (1999). Gan To Kagaku Ryoho, 26, 619–629.

  • Arisawa K, Katamine S, Kamihira S, Kurokawa K, Sawada T, Soda M, Doi H, Saito H and Shirahama S . (2002). Cancer Causes Control, 13, 657–663.

  • Arnulf B, Thorel M, Poirot Y, Tamouza R, Boulanger E, Jaccard A, Oksenhendler E, Hermine O and Pique C . (2004). Leukemia, 18, 126–132.

  • Bangham CR . (2003). Int. J. Hematol., 78, 297–303.

  • Barnard AL, Igakura T, Tanaka Y, Taylor GP and Bangham CR . (2005). Blood, 14 April, [E-pub ahead of print].

  • Besson C, Panelatti G, Delaunay C, Gonin C, Brebion A, Hermine O and Plumelle Y . (2002). Leuk. Lymphoma, 43, 2275–2279.

  • Blaheta RA and Cinatl Jr J . (2002). Med. Res. Rev., 22, 492–511.

  • Borg A, Yin JA, Johnson PR, Tosswill J, Saunders M and Morris D . (1996). Br. J. Haematol., 94, 713–715.

  • Cavrois M, Leclercq I, Gout O, Gessain A, Wain-Hobson S and Wattel E . (1998). Oncogene, 17, 77–82.

  • Dierov J, Sawaya BE, Prosniak M and Gartenhaus RB . (1999). Clin. Cancer Res., 5, 2540–2547.

  • Doi K, Wu X, Taniguchi Y, Yasunaga JI, Satou Y, Okayama A, Nosaka K and Matsuoka M . (2005). Blood, 19 April, [E-pub ahead of print].

  • Etoh K, Tamiya S, Yamaguchi K, Okayama A, Tsubouchi H, Ideta T, Mueller N, Takatsuki K and Matsuoka M . (1997). Cancer Res., 57, 4862–4867.

  • Etoh K, Yamaguchi K, Tokudome S, Watanabe T, Okayama A, Stuver S, Mueller N, Takatsuki K and Matsuoka M . (1999). Int. J. Cancer, 81, 859–864.

  • Ezaki K, Hirano M, Ohno R, Yamada K, Naito K, Hirota Y, Shirakawa S and Kimura K . (1991). Cancer, 68, 695–698.

  • Fontenot JD and Rudensky AY . (2005). Nat. Immunol., 6, 331–337.

  • Franchini G, Fukumoto R and Fullen JR . (2003). Int. J. Hematol., 78, 280–296.

  • Fukushima T, Miyazaki Y, Honda S, Kawano F, Moriuchi Y, Masuda M, Tanosaki R, Utsunomiya A, Uike N, Yoshida S, Okamura J and Tomonaga M . (2005). Leukemia, 19, 829–834.

  • Furukawa Y, Kubota R, Tara M, Izumo S and Osame M . (2001). Blood, 97, 987–993.

  • Gatza ML, Watt JC and Marriott SJ . (2003). Oncogene, 22, 5141–5149.

  • Gill PS, Harrington Jr W, Kaplan MH, Ribeiro RC, Bennett JM, Liebman HA, Bernstein-Singer M, Espina BM, Cabral L, Allen S, Kornblau S, Pike MC and Levine AM . (1995). N. Engl. J. Med., 332, 1744–1748.

  • Han Y, Lassen K, Monie D, Sedaghat AR, Shimoji S, Liu X, Pierson TC, Margolick JB, Siliciano RF and Siliciano JD . (2004). J. Virol., 78, 6122–6133.

  • Harasawa H, Yamada Y, Kudoh M, Sugahara K, Soda H, Hirakata Y, Sasaki H, Ikeda S, Matsuo T, Tomonaga M, Nobori T and Kamihira S . (2002). Leukemia, 16, 1799–1807.

  • Harashima N, Kurihara K, Utsunomiya A, Tanosaki R, Hanabuchi S, Masuda M, Ohashi T, Fukui F, Hasegawa A, Masuda T, Takaue Y, Okamura J and Kannagi M . (2004). Cancer Res., 64, 391–399.

  • Hermine O, Allard I, Levy V, Arnulf B, Gessain A and Bazarbachi A . (2002). Hematol. J., 3, 276–282.

  • Hermine O, Bouscary D, Gessain A, Turlure P, Leblond V, Franck N, Buzyn-Veil A, Rio B, Macintyre E, Dreyfus F and Bazarbachi A . (1995). N. Engl. J. Med., 332, 1749–1751.

  • Hermine O, Dombret H, Poupon J, Arnulf B, Lefrere F, Rousselot P, Damaj G, Delarue R, Fermand JP, Brouet JC, Degos L, Varet B, de The H and Bazarbachi A . (2004). Hematol. J., 5, 130–134.

  • Igakura T, Stinchcombe JC, Goon PK, Taylor GP, Weber JN, Griffiths GM, Tanaka Y, Osame M and Bangham CR . (2003). Science, 299, 1713–1716.

  • Jeang KT, Giam CZ, Majone F and Aboud M . (2004). J. Biol. Chem., 279, 31991–31994.

  • Jones KS, Akel S, Petrow-Sadowski C, Huang Y, Bertolette DC and Ruscetti FW . (2005). J. Immunol., 174, 4262–4270.

  • Jordan A, Bisgrove D and Verdin E . (2003). EMBO J., 22, 1868–1877.

  • Kami M, Hamaki T, Miyakoshi S, Murashige N, Kanda Y, Tanosaki R, Takaue Y, Taniguchi S, Hirai H, Ozawa K and Kasai M . (2003). Br. J. Haematol., 120, 304–309.

  • Kannagi M, Harashima N, Kurihara K, Utsunomiya A, Tanosaki R and Masuda M . (2004). Expert Rev. Anticancer Ther., 4, 369–376.

  • Karube K, Ohshima K, Tsuchiya T, Yamaguchi T, Kawano R, Suzumiya J, Utsunomiya A, Harada M and Kikuchi M . (2004). Br. J. Haematol., 126, 81–84.

  • Katsuki T, Katsuki K, Imai J and Hinuma Y . (1987). Jpn. J. Cancer Res., 78, 639–642.

  • Kiyokawa T, Yamaguchi K, Takeya M, Takahashi K, Watanabe T, Matsumoto T, Lee SY and Takatsuki K . (1987). Cancer, 59, 1187–1191.

  • Koiwa T, Hamano-Usami A, Ishida T, Okayama A, Yamaguchi K, Kamihira S and Watanabe T . (2002). J. Virol., 76, 9389–9397.

  • Krueger A, Fas SC, Baumann S and Krammer PH . (2003). Immunol. Rev., 193, 58–69.

  • Kuramochi M, Fukuhara H, Nobukuni T, Kanbe T, Maruyama T, Ghosh HP, Pletcher M, Isomura M, Onizuka M, Kitamura T, Sekiya T, Reeves RH and Murakami Y . (2001). Nat. Genet., 27, 427–430.

  • Kuwazuru Y, Hanada S, Furukawa T, Yoshimura A, Sumizawa T, Utsunomiya A, Ishibashi K, Saito T, Uozumi K, Maruyama M, Ishizawa M, Arima T and Akiyama S-I . (1990). Blood, 76, 2065–2071.

  • Li HC, Biggar RJ, Miley WJ, Maloney EM, Cranston B, Hanchard B and Hisada M . (2004). J. Infect. Dis., 190, 1275–1278.

  • Lymphoma Study Group Shimoyama M Ota K Kikuchi M Tominaga S and Yunoki K . (1982). Jpn J Clin Oncol, 12, 227–238.

  • Mahieux R and Hermine O . (2005). Leuk Lymphoma, 46, 347–355.

  • Makino T, Nakahara K, Takatsuka Y, Shimotakahara S, Utsunomiya A, Hanada S, Tokunaga M and Arima T . (1994). Rinsho Ketsueki, 35, 42–48.

  • Manel N, Kim FJ, Kinet S, Taylor N, Sitbon M and Battini JL . (2003). Cell, 115, 449–459.

  • Matsuoka M and Jeang KT . (2005). Cancer Res., 65, 4467–4470.

  • Matsushita K, Matsumoto T, Ohtsubo H, Fujiwara H, Imamura N, Hidaka S, Kukita T, Tei C, Matsumoto M and Arima N . (1999). Leuk. Lymphoma, 36, 67–75.

  • Matutes E, Taylor GP, Cavenagh J, Pagliuca A, Bareford D, Domingo A, Hamblin M, Kelsey S, Mir N and Reilly JT . (2001). Br. J. Haematol., 113, 779–784.

  • Mercieca J, Matutes E, Dearden C, MacLennan K and Catovsky D . (1994). J. Clin. Oncol., 12, 2588–2593.

  • Mittelstadt PR and Ashwell JD . (1998). Mol. Cell. Biol., 18, 3744–3751.

  • Mori N, Matsuda T, Tadano M, Kinjo T, Yamada Y, Tsukasaki K, Ikeda S, Yamasaki Y, Tanaka Y, Ohta T, Iwamasa T, Tomonaga M and Yamamoto N . (2004). J. Virol., 78, 4582–4590.

  • Mori N, Yamada Y, Ikeda S, Yamasaki Y, Tsukasaki K, Tanaka Y, Tomonaga M, Yamamoto N and Fujii M . (2002). Blood, 100, 1828–1834.

  • Morris JC, Janik JE, Turner M, Lee C, Top L, Jaffe ES, Stetler-Stevenson M, Blessing JJ, Fleisher TA and Waldmann T . (2001). 10th International Conference on Human Retrovirology: HTLV and Related Viruses, Vol, 17 Suppl. AIDS Res Hum Retroviruses: Dublin, pp. S29.

    Google Scholar 

  • Nakane M, Ohashi K, Sato Y, Moriya A, Inoue T, Mori S, Tanikawa S, Akiyama H, Maeda Y, Sasaki T, Karasawa K, Okuyama Y, Hiruma K and Sakamaki H . (1999). Bone Marrow Transplant, 24, 219–221.

  • Nasr R, Rosenwald A, El-Sabban ME, Arnulf B, Zalloua P, Lepelletier Y, Bex F, Hermine O, Staudt L, de The H and Bazarbachi A . (2003). Blood, 101, 4576–4582.

  • Nosaka K, Miyamoto T, Sakai T, Mitsuya H, Suda T and Matsuoka M . (2002). Blood, 99, 634–640.

  • Ogata M, Ogata Y, Imamura T, Ohtsuka E, Kikuchi H, Utsunomiya A, Yashiki S, Sonoda S and Nasu M . (2002). Bone Marrow Transplant, 30, 699–701.

  • Ohashi T, Hanabuchi S, Kato H, Tateno H, Takemura F, Tsukahara T, Koya Y, Hasegawa A, Masuda T and Kannagi M . (2000). J. Virol., 74, 9610–9616.

  • Ohno R, Masaoka T, Shirakawa S, Sakamoto S, Hirano M, Hanada S, Yasunaga K, Yokomaku S, Mitomo Y, Nagai K, Yamada K and Furue H . (1993). Cancer, 71, 2217–2221.

  • Okamura J, Utsunomiya A, Tanosaki R, Uike N, Sonoda S, Kannagi M, Tomonaga M, Harada M, Kimura N, Masuda M, Kawano F, Yufu Y, Hattori H, Kikuchi H and Saburi Y . (2005). Blood, 105, 4143–4145.

  • Okayama A, Stuver S, Matsuoka M, Ishizaki J, Tanaka G, Kubuki Y, Mueller N, Hsieh CC, Tachibana N and Tsubouchi H . (2004). Int. J. Cancer, 110, 621–625.

  • Okochi K, Sato H and Hinuma Y . (1984). Vox. Sang, 46, 245–253.

  • Pawson R, Richardson DS, Pagliuca A, Kelsey SM, Hoque S, Breuer J, Newland AC and Mufti GJ . (1998). Leuk. Lymphoma, 31, 177–185.

  • Sasaki H, Nishikata I, Shiraga T, Akamatsu E, Fukami T, Hidaka T, Kubuki Y, Okayama A, Hamada K, Okabe H, Murakami Y, Tsubouchi H and Morishita K . (2005). Blood, 105, 1204–1213.

  • Satou Y, Nosaka K, Koya Y, Yasunaga JI, Toyokuni S and Matsuoka M . (2004). Leukemia, 18, 1357–1363.

  • Shimoyama M . (1992). Advances in Adult T-cell Leukaemia and HTLV-I Research. Takatsuki K, Hinuma Y, Yoshida M (eds). Japanese Scientific Societies Press: Tokyo, pp. 43–56.

    Google Scholar 

  • Shimoyama M, Ota K, Kikuchi M, Yunoki K, Konda S, Takatsuki K, Ichimaru M, Tominaga S, Tsugane S and Minato K . (1988). J. Clin. Oncol., 6, 1088–1097.

  • Siegel RS, Gartenhaus RB and Kuzel TM . (2001). Curr. Treat. Options Oncol., 2, 291–300.

  • Taguchi H, Kinoshita KI, Takatsuki K, Tomonaga M, Araki K, Arima N, Ikeda S, Uozumi K, Kohno H, Kawano F, Kikuchi H, Takahashi H, Tamura K, Chiyoda S, Tsuda H, Nishimura H, Hosokawa T, Matsuzaki H, Momita S, Yamada O and Miyoshi I . (1996). J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 12, 182–186.

  • Taguchi T, Ohta K, Hotta T, Shirakawa S, Masaoka T and Kimura I . (1997). Gan To Kagaku Ryoho, 24, 1263–1271.

  • Tajima K, Amakawa R, Uehira K, Matsumoto N, Shimizu T, Miyazaki Y, Fujimoto M, Kishimoto Y and Fukuhara S . (2000). Int. J. Hematol., 71, 290–293.

  • Takeda S, Maeda M, Morikawa S, Taniguchi Y, Yasunaga J, Nosaka K, Tanaka Y and Matsuoka M . (2004). Int. J. Cancer, 109, 559–567.

  • Tamiya S, Matsuoka M, Etoh K, Watanabe T, Kamihira S, Yamaguchi K and Takatsuki K . (1996). Blood, 88, 3065–3073.

  • Tamiya S, Matsuoka M, Takemoto S, Shimizu K, Yamaguchi K, Mita S, Uchino M, Ando M, Miyaguni T, Kuniyoshi K and Takatsuki K . (1995). Leukemia, 9, 1768–1770.

  • Tan C and Waldmann TA . (2002). Cancer Res., 62, 1083–1086.

  • Tanaka G, Okayama A, Watanabe T, Aizawa S, Stuver S, Mueller N, Hsieh CC and Tsubouchi H . (2005). J. Infect. Dis., 191, 1140–1147.

  • Taylor GP, Gessain A, Popescu DM, Zehender G, Padua E, Soriano V, Anderson S, Tosswill JHC and Weber JN . (2001). AIDS Res. Hum. Retroviruses, 17 (Suppl 1), S-69.

  • Thompson C and Powrie F . (2004). Curr. Opin. Pharmacol., 4, 408–414.

  • Tobinai K, Shimoyama M, Inoue S, Takayasu S, Mikuni C, Kozuru M, Oda S and Nakajima H . (1992). Jpn. J. Clin. Oncol., 22, 164–171.

  • Tobinai K, Shimoyama M, Takatsuki K, Tomonaga M, Araki K and Arima N . (1994). Proc. Am. Soc. Oncol., 13, 378.

  • Tobinai K, Uike N, Saburi Y, Chou T, Etoh T, Masuda M, Kawano F, Matsuoka M, Taguchi H, Makino T, Asano Y, Tamura K and Ohashi Y . (2003). Int. J. Hematol., 77, 512–517.

  • Toyota M, Ho C, Ahuja N, Jair KW, Li Q, Ohe-Toyota M, Baylin SB and Issa JP . (1999). Cancer Res., 59, 2307–2312.

  • Tsuda H, Takatsuki K, Ohno R, Masaoka T, Okada K, Shirakawa S, Ohashi Y and Ota K . (1994). Br. J. Cancer, 70, 771–774.

  • Tsukasaki K, Ikeda S, Murata K, Maeda T, Atogami S, Sohda H, Momita S, Jubashi T, Yamada Y, Mine M, Kamihira S and Tomonaga M . (1993). Leuk. Res., 17, 157–166.

  • Tsukasaki K, Tobinai K, Shimoyama M, Kozuru M, Uike N, Yamada Y, Tomonaga M, Araki K, Kasai M, Takatsuki K, Tara M, Mikuni C and Hotta T . (2003). Int. J. Hematol., 77, 164–170.

  • Uike N, Choi I, Tokoro A, Goto T, Yufu Y, Kozuru M and Tobinai K . (1998). Intern. Med., 37, 411–413.

  • Uozumi K, Hanada S, Ohno N, Ishitsuka K, Shimotakahara S, Otsuka M, Chyuman Y, Nakahara K, Takeshita T, Kuwazuru Y, Saito T, Makino T, Iwahashi M, Utsunomiya A and Arima T . (1995). Leuk. Lymphoma, 18, 317–323.

  • Utsunomiya A, Miyazaki Y, Takatsuka Y, Hanada S, Uozumi K, Yashiki S, Tara M, Kawano F, Saburi Y, Kikuchi H, Hara M, Sao H, Morishima Y, Kodera Y, Sonoda S and Tomonaga M . (2001). Bone Marrow Transplant, 27, 15–20.

  • Waldmann TA, Goldman CK, Bongiovanni KF, Sharrow SO, Davey MP, Cease KB, Greenberg SJ and Longo DL . (1988). Blood, 72, 1805–1816.

  • Waldmann TA, White JD, Carrasquillo JA, Reynolds JC, Paik CH, Gansow OA, Brechbiel MW, Jaffe ES, Fleisher TA, Goldman CK, Top LE, Bamford R, Zaknoen E, Roessler E, Kasten-Sportes C, England R, Litou H, Johnson JA, Jackson-White T, Manns A, Hanchard B, Junghans RP and Nelson DL . (1995). Blood, 86, 4063–4075.

  • Waldmann TA, White JD, Goldman CK, Top L, Grant A, Bamford R, Roessler E, Horak ID, Zaknoen S, Kasten-Sportes C, England R, Horak E, Mishra B, Dipre M, Hale P, Fleisher TA, Junghans RP, Jaffe ES and Nelson DL . (1993). Blood, 82, 1701–1712.

  • Watanabe T, Yamaguchi K, Takatsuki K, Osame M and Yoshida M . (1990). J. Exp. Med., 172, 759–765.

  • Welles SL, Tachibana N, Okayama A, Shioiri S, Ishihara S, Murai K and Mueller NE . (1994). Int. J. Cancer, 56, 337–340.

  • Wu X, Li Y, Crise B and Burgess SM . (2003). Science, 300, 1749–1751.

  • Yamada Y, Hatta Y, Murata K, Sugawara K, Ikeda S, Mine M, Maeda T, Hirakata Y, Kamihira S, Tsukasaki K, Ogawa S, Hirai H, Koeffler HP and Tomonaga M . (1997). J. Clin. Oncol., 15, 1778–1785.

  • Yamada Y and Tomonaga M . (2003). Leuk. Lymphoma, 44, 611–618.

  • Yamada Y, Tomonaga M, Fukuda H, Hanada S, Utsunomiya A, Tara M, Sano M, Ikeda S, Takatsuki K, Kozuru M, Araki K, Kawano F, Niimi M, Tobinai K, Hotta T and Shimoyama M . (2001). Br. J. Haematol., 113, 375–382.

  • Yasunaga J, Sakai T, Nosaka K, Etoh K, Tamiya S, Koga S, Mita S, Uchino M, Mitsuya H and Matsuoka M . (2001). Blood, 97, 3177–3183.

  • Yasunaga J, Taniguchi Y, Nosaka K, Yoshida M, Satou Y, Sakai T, Mitsuya H and Matsuoka M . (2004). Cancer Res., 64, 6002–6009.

  • Yoshida M . (2001). Annu. Rev. Immunol., 19, 475–496.

  • Yoshida M, Nosaka K, Yasunaga J, Nishikata I, Morishita K and Matsuoka M . (2004). Blood, 103, 2753–2760.

  • Zhang Z, Zhang M, Goldman CK, Ravetch JV and Waldmann TA . (2003). Cancer Res., 63, 6453–6457.

Download references

Author information

Authors and Affiliations

  1. Department of GU Medicine & Communicable Diseases, Faculty of Medicine, Imperial College, Norfolk Place, London, W2 1PG, UK

    Graham P Taylor

  2. Laboratory of Virus Immunology, Center for AIDS Research, Institute for Virus Research, Kyoto University, 53 Shogoin Kawahara-cho, Sakyo-ku, 606-8507, Kyoto, Japan

    Masao Matsuoka

Authors
  1. Graham P Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masao Matsuoka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masao Matsuoka.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taylor, G., Matsuoka, M. Natural history of adult T-cell leukemia/lymphoma and approaches to therapy. Oncogene 24, 6047–6057 (2005). https://doi.org/10.1038/sj.onc.1208979

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208979

Keywords

This article is cited by

Search

Advanced search

Quick links